ORAMED PHARMACEUTICALS INC. (ORMP) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $2.00M | — |
| 2023 | $1.34M | -50.4% |
| 2022 | $2.70M | +0.0% |
| 2021 | $2.70M | -0.3% |
| 2020 | $2.71M | +0.3% |
| 2019 | $2.70M | +10.4% |
| 2018 | $2.45M | -0.3% |
| 2017 | $2.46M | +283.2% |
| 2016 | $641.0K | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $2.00M | — |
| 2023 | $1.34M | -50.4% |
| 2022 | $2.70M | +0.0% |
| 2021 | $2.70M | -0.3% |
| 2020 | $2.71M | +0.3% |
| 2019 | $2.70M | +10.4% |
| 2018 | $2.45M | -0.3% |
| 2017 | $2.46M | +283.2% |
| 2016 | $641.0K | — |